Roberts Wealth Advisors LLC raised its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 5.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 28,634 shares of the company’s stock after buying an additional 1,564 shares during the period. Procter & Gamble makes up approximately 1.4% of Roberts Wealth Advisors LLC’s portfolio, making the stock its 24th largest position. Roberts Wealth Advisors LLC’s holdings in Procter & Gamble were worth $4,571,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. RPg Family Wealth Advisory LLC bought a new position in Procter & Gamble in the third quarter valued at approximately $33,000. Costello Asset Management INC grew its stake in shares of Procter & Gamble by 2,142.9% in the third quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after buying an additional 300 shares in the last quarter. William B. Walkup & Associates Inc. bought a new stake in Procter & Gamble during the second quarter worth $58,000. Mendota Financial Group LLC lifted its stake in Procter & Gamble by 58.0% in the fourth quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock valued at $63,000 after acquiring an additional 138 shares during the last quarter. Finally, Itau Unibanco Holding S.A. grew its position in shares of Procter & Gamble by 138.7% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company’s stock valued at $69,000 after acquiring an additional 233 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Up 1.8 %
Shares of Procter & Gamble stock opened at $164.57 on Thursday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 12-month low of $152.06 and a 12-month high of $180.43. The company has a market capitalization of $387.56 billion, a price-to-earnings ratio of 28.37, a PEG ratio of 3.63 and a beta of 0.45. The firm’s 50-day moving average price is $169.01 and its two-hundred day moving average price is $169.41.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Insider Activity
In other news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Barclays cut their target price on shares of Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. UBS Group reduced their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Wells Fargo & Company reduced their price objective on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $179.65.
View Our Latest Report on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- The 3 Best Retail Stocks to Shop for in August
- Oracle Announces Game-Changing News for the AI Industry
- 3 Monster Growth Stocks to Buy Now
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is the Shanghai Stock Exchange Composite Index?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.